热点
关于我们
xx
xx
"
Alnylam
" 相关文章
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
INVESTOR
2025-09-29T02:49:42.000000Z
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
INVESTOR
2025-09-29T02:49:42.000000Z
小核酸的风,继续吹
钛媒体:引领未来商业与生活新知
2025-09-18T02:41:45.000000Z
认知颠覆战,当Alnylam逼近4000亿
36kr
2025-08-03T23:42:01.000000Z
64%临床成功率,你信吗?
钛媒体:引领未来商业与生活新知
2024-07-01T10:35:21.000000Z
64%临床成功率的创新药,值得信任吗?
界面快报
2024-07-01T05:00:56.000000Z
RNAi正在发起一场降维打击
界面快报
2024-06-26T03:30:58.000000Z